News

Alleged ₦81.2bn Tree Planting Scandal: House Committee Exonerates NAGGW

Published

2 years ago

December 10, 2023

The House of Representatives Adhoc Committee set up to investigate the utilisation of Ecological Fund released to the National Agency for the Great Green Wall (NAGGW), has absolved the Agency’s management of allegations of fraud allegations leveled against it.

The Honorable Ismaila Dabo-led Adhoc committee was set up in July, to investigate allegations of mismanagement of funds released to the agency from the Ecological Fund.

This followed a motion titled: “The Need to Investigate the Utilization of Ecological Funds Released to the Great Green Wall by the International Organizations from 2015 to Date; and All Federal Allocations to the National Agency for the Great Green Wall as well as all Contract Awarded to Various Contractors for the Project from 2019 to Date.” which was sponsored by Honourable Ali Lawan Shettima.

The House panel, in a report obtained by Vanguard, on Sunday, revealed that it reached the conclusion after considering oral evidence and reviewing documents made available to it by those who testified before the 15 member committee.

At the inaugural sitting of the Adhoc Committee, the management team of the agency was invited to shed light on allegations that it spent ₦81.2 billion on the planting of 21 million trees across 11 frontline states.

The States listed were: Kebbi, Sokoto, Zamfara, Katsina, Kano, Jigawa, Bauchi, Gombe, Adamawa, Yobe and Borno.

The House Committee equally queried the agency over discrepancies in some of its expenditures.

Director General/CEO of National Agency for the Great Green Wall (NAGGW), Dr. Yusuf Maina Bukar, in his presentation before the Committee in September, denied the allegation while making clarifications on budgetary allocations to the agency.

He informed the committee that he assumed office in April 2022, and that berifiable records show that the sum of ₦53,425,423,874.34 was the amount released to the Agency from inception to July 2023, as against the sum of N81.2 bn which the Agency was alleged to have spent.

Bukar insisted the Agency has not acted outside its mandate in the implementation of its mandate.

According to him, not all of the ₦53,425,423,874.34 received were directly spent for tree planting activities as some uninformed persons would want Nigerians to believe.

He said, “The NAGGW cost of planting, from inception in 2015 to July 2023 is ₦5,145,735,470.15

“That the approximate sum of ₦7.2 billion balance in the Agency’s account are liabilities already committed to ongoing contracts that have already been awarded.

“All unutilized funds from capital appropriation are refunded to Federal Government TSA account at the end of the financial year where applicable.”

The Honourable Dabo fifteen-man Committee in its report also faulted the claim that the agency received the sum of ₦81.2 bn noting that, “Evidence from the Hearing indicates that the NAGGW received a total sum of ₦53,425,423,874.34 (Fifty-three Billion, Four Hundred and Twenty-five Million, Four Hundred and Twenty-three Thousand, Eight Hundred- and Seventy-four-naira, Thirty-four Kobo) only from inception in 2015 to July, 2023.”

In the course of its investigations, the Committee also discovered that the Agency didn’t receive budgetary allocation for 2015; and that ecological funding was not released to the agency until 2019.

The House panel also discovered that, “the percentage of ecological funding going to the Agency was reduced from 15% provided for by the Act to just 5% with effect from January 2020 to date.”

The report acknowledged the paucity and untimely release of funds, inability to access foreign assistance and absence of a Governing Board as some of the factors hindering the performance of the agency.

The lawmakers equally expressed displeasure over the unilateral reduction in the statutory allocation to the agency by fiat, and urged government, as a matter of urgency revert the Ecological Fund releases to the agency back to 15 percent as provided for by the NAGGW Act.

The report further read in part, “That the total sum of ₦20,168,363,662.18 (Twenty Billion, One Hundred and Sixty- Eight Million, Three Hundred and Sixty-Three Thousand, Six Hundred- And Sixty-Two-Naira, Eighteen Kobo) only being the shortfall of the reduction from Ecological Fund for January, 2020 to date, be immediately released to the Agency to fund its activities;”

Other recommendations contained in the report read : “Similarly, the Ecological fund office should calculate remit to the NAGGW the total sums due to the agency from the Ecological Fund from 2015 to 2018;

“Urge the National Agency for the Great Green Wall to as a matter of urgency include the frontline states of Adamawa, Bauchi and Gombe States in the fourth phase of the a forestation projects which is to commence soon.

“There is urgent need for the agency to undertake recruitment of staff, especially for its offices at the front line states;

“Need for a greater collaboration and synergy between the NAGGW and the Federal Ministry of Environment;”

“Urge the Federal Government to constitute a Governing Board for the National Agency for the Great Green Wall;

“Need for extensive enlightenment of the general public on the sustainable use of the forest for preservation.”

Aside from submissions by the Federal Ministry of Environment, the Central Bank of Nigeria, Office of the Accountant General of the Federation and the Ecological Project Office, the Committee also undertook on-the-spot assessment visit to projects sites in some of the frontline states, namely; Kano, Jigawa and Sokoto State.

News

Togo, Niger, Benin Owe Nigeria Over $17.8m For Supplied Electricity – NERC

Published

3 hours ago

January 8, 2026

Editor

Nigeria’s electricity regulator has disclosed that three neighbouring countries, Togo, Niger and Benin, are indebted to Nigeria to the tune of $17.8 million, equivalent to more than N25 billion at prevailing exchange rates, for power supplied under bilateral electricity agreements.

The Nigerian Electricity Regulatory Commission, NERC, made this known in its Third Quarter 2025 report, which reviewed market performance within the Nigerian Electricity Supply Industry, NESI.

According to the report, the international customers were billed a total of $18.69 million by the Market Operator for electricity supplied during the third quarter of 2025. However, only $7.125 million was paid, leaving an unpaid balance of $11.56 million for the period under review.

NERC also revealed that the same international offtakers had outstanding legacy debts amounting to $14.7 million from previous quarters. Of this amount, $7.84 million was settled, leaving a residual balance of $6.23 million.

When combined with the Q3 2025 shortfall, the total outstanding debt stood at $17.8 million, which translates to about N25.36 billion at an exchange rate of N1,425 to one US dollar.

The regulator identified the international electricity customers as Compagnie Énergie Électrique du Togo, Société Béninoise d’Énergie Électrique of Benin Republic, and Société Nigérienne d’Électricité of Niger Republic.

NERC stated that the three utilities collectively paid just $7.125 million against the $18.69 million invoice issued for electricity supplied in the third quarter, resulting in a remittance performance of 38.09 per cent.

This meant that more than half of the billed amount remained unpaid at the close of the quarter.

The commission explained that the electricity exported to the three countries was generated by grid-connected Nigerian generation companies and delivered through cross-border bilateral power supply arrangements.

By contrast, NERC reported a stronger payment performance among domestic bilateral customers. According to the report, local customers paid N3.19 billion out of the N3.64 billion invoiced for the same quarter, representing a remittance rate of 87.61 per cent.

The regulator further noted that some bilateral customers, both international and domestic, made additional payments to offset outstanding invoices from earlier quarters.

Specifically, the Market Operator received $7.84 million from international customers and N1.3 billion from domestic customers in settlement of previous obligations.

Beyond bilateral transactions, NERC disclosed that Nigeria’s 11 electricity distribution companies remitted a total of N381.29 billion to the Nigerian Bulk Electricity Trading Plc and the Market Operator in the third quarter of 2025. This was out of a cumulative invoice of N400.48 billion, translating to an overall remittance performance of 95.21 per cent.

The commission said the figures were derived from reconciled market settlement data submitted as of December 18, 2025, as part of its statutory evaluation of the commercial health and performance of the electricity market.

News

Expert Identify Foods That Increase Hypertension Medication’s Effectiveness

Published

11 hours ago

January 8, 2026

Editor

Hypertension remains one of the leading causes of premature death worldwide, contributing significantly to heart disease, stroke, and kidney failure. Despite the availability of effective antihypertensive drugs, long-term control of high blood pressure is often challenging because of drug resistance, side effects, and poor adherence.

This has fueled growing scientific interest in complementary strategies that can enhance drug efficacy while minimising toxicity. One promising approach is the combination of conventional antihypertensive medications with herbs and spices in many kitchens.

Recent evidence suggests that augmenting modern antihypertensive drugs with foods rich in p-coumaric acid, a naturally occurring phenolic acid, may offer a novel and effective strategy for blood pressure control.

Phenolic compounds, commonly found in fruits, vegetables, whole grains, and legumes, are known for their antioxidant, anti-inflammatory, and blood vessel–protective properties.

In a study, researchers investigated the combined effects of lisinopril, a widely used antihypertensive drugs and p-coumaric acid on hypertension.

They reported in the Comparative Clinical Pathology that p-coumaric acid enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

The study used an established animal model in which hypertension was induced in rats through oral administration of L-NAME, a compound known to suppress nitric oxide production and raise blood pressure.

Following the induction of hypertension, the animals were treated for 14 days with p-coumaric acid (at two different doses), lisinopril alone, or a combination of both.

Untreated hypertensive rats showed significantly elevated activities of key enzymes linked to high blood pressure such as ACE, arginase, acetylcholinesterase, and phosphodiesterase-5 along with increased lipid peroxidation, an indicator of oxidative stress. At the same time, levels of nitric oxide, a critical molecule for blood vessel relaxation, were markedly reduced.

By contrast, rats treated with a combination of lisinopril and p-coumaric acid experienced notable improvements. Blood pressure was better controlled; harmful enzyme activities were reduced, oxidative stress declined, and nitric oxide levels increased. These improvements were mirrored in the tissues the heart compared with untreated hypertensive animals.

They said that the findings suggest that p-coumaric acid may enhance the antihypertensive action of lisinopril, potentially allowing for improved blood pressure control without increasing drug dosage.

This drug–food interaction model is particularly important in the circumstance of long-term hypertension management. Many patients rely on lifelong medication, and strategies that can improve treatment outcomes while reducing side effects are highly desirable.

The study also reinforces the growing recognition that diet is not merely supportive but can be biologically active in disease control.

The use of medicinal plants and plant-based therapies in the management of hypertension is deeply rooted in traditional medicine across many cultures. While such practices have often existed outside conventional healthcare systems, modern scientific research is now providing evidence-based explanations for their effectiveness.

While these findings are based on animal studies and cannot yet be directly translated into clinical recommendations for humans, they open the door to future research on dietary strategies that can safely complement antihypertensive drugs.

Further clinical studies are needed to determine appropriate dosages, safety profiles, and real-world effectiveness.

In the fight against hypertension, the future may lie not only in new drugs, but also in smarter combinations, where medicine and nutrition work together to deliver better, safer outcomes for patients.

Such nutrition to help maintain healthy blood pressure includes garlic, potatoes, walnuts,tomato and tomato products, legumes and citrus fruits (grapefruits and oranges).
(TRIBUNE)

News

Researchers Develop Treatment For Advanced Prostate Cancer

Published

11 hours ago

January 8, 2026

Editor

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy.

The innovative approach, according to the researchers, targets prostate cancer cells just as successfully as existing treatments while causing significantly less harm to salivary glands.

For many people with prostate cancer, it relieves the extreme dry mouth that makes speaking, chewing, and swallowing nearly impossible.

According to the findings published in Molecular Imaging and Biology, the treatment targets PSMA (Prostate-Specific Membrane Antigen), a protein present in high numbers on prostate cancer cells.

Radioligand therapy (RTL) attaches radioactive material to a targeting molecule that acts like a GPS system, guiding the radiation directly to cancer cells while avoiding healthy tissue.

Current PSMA-targeted radioligand therapy is one of the most promising precision cancer treatments for end-stage prostate cancer because it acts as a “smart bomb” that locates and destroys cancer cells.

The downside, however, is that this therapy often causes severe salivary gland damage, resulting in extreme dry mouth that can be so debilitating that patients choose to stop treatment that might save their lives.

James P. Basilion, professor in the Department of Biomedical Engineering at Case Western Reserve and co-leader of the Cancer Imaging Program at the Case Comprehensive Cancer Centre (Case CCC), explained that various strategies to mitigate this side effect have been attempted before, with limited success.

According to the study, PSMA-1-DOTA has a four-fold greater affinity for prostate cancer cells than current therapies.

In addition to having the same tumour-fighting effectiveness as the current standard radioligand therapy, it also significantly reduced damage to the tear and salivary glands, almost eliminating the risk of dry mouth.

This discovery has the potential to significantly alter the treatment of prostate cancer by making PSMA-targeted therapy an earlier intervention rather than a “last resort.”

The research included comprehensive testing on mouse models and in a human patient with metastatic prostate cancer at the Technical University of Munich in Germany.

The patient study confirmed the lab findings, showing the new treatment avoided the salivary glands (potentially preventing dry mouth) while still finding and attacking prostate cancer cells.

The researchers, from now on, are preparing for clinical trials late this year on about 12 prostate patients to validate the promising results and establish the most effective dosing procedures.
(TRIBUNE)